logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
H

Hai Huang

sun yat-sen university
H指数:48
被引数:9,353

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Bridging practice and precision: a quantitative HER2 protein assay ready for clinical use in guiding trastuzumab deruxtecan therapy

连接实践与精准：一种定量HER2蛋白检测方法，可用于指导曲妥珠单抗德鲁克替康疗法

Frontiers in Oncology
IF3.3
2026-04-270
OAAI
JH Junmei Hao †; XF Xiaochun Fei †; FZ Fangfang Zou; QH Qian Hu; LD Linlin Du; LY Liya Yu; XB Xuanye Bai; SB Shasha Bi; QC Qinghua Cao; WC Weishan Chen; QD Qun Dai; TG Tingting Guo; HH Hai Huang; WJ Wenwei Jiang; BL Baohua Li; LL Lixia Li; JL Jingjing Liu; TL Tong Liu; XL Xiaoqin Liu; JL Jiahong Lyu; YP Yue Pan; XS Xiaoqing Shao; FT Fangrong Tang; TW Tingting Wang; CZ Cuiping Zhang; YZ Yongcun Zhu; JT Job Tien Chiang Liu; NS Nicole Salazar; SZ Shukun Zhang; JZ Jiandi Zhang; XC Xiaosong Chen; CW Chaofu Wang
Clinical efficacy of hepatic arterial infusion chemotherapy combined with transhepatic arterial embolization plus lenvatinib and tislelizumab or transarterial chemoembolization combined with lenvatinib plus tislelizumab in the treatment of advanced hepatocellular carcinoma

肝动脉灌注化疗联合经肝动脉栓塞术加仑伐替尼和替雷利珠单抗，或经动脉化疗栓塞联合仑伐替尼加替雷利珠单抗治疗晚期肝细胞癌的临床疗效

Frontiers in Oncology
IF3.3
2025-12-020
OAAI
Zha Peng†; Yaqiong Wang†; Boyu Chen; Zhuangrong Zhu; Chengyi He; Yang Wei; Hai Huang

研究方向

暂未获取到该数据
A
Allan Tsung
H 指数:84论文数:598被引数:2.5万
T
Timothy R. Billiar
H 指数:140论文数:1,167被引数:7.8万
M
Meihong Deng
H 指数:27论文数:97被引数:2,861
张
张洪吉
H 指数:30论文数:126被引数:3,989
P
Patricia Loughran
H 指数:46论文数:195被引数:9,110
S
Samer Tohme
H 指数:35论文数:188被引数:6,450
H
Hamza O. Yazdani
H 指数:19论文数:83被引数:2,983
M
Michael P. Stone
H 指数:39论文数:274被引数:5,172
D
David A. Geller
H 指数:93论文数:773被引数:3.5万
王好 封面图
王好
H 指数:49论文数:361被引数:7,708